tacrolimus

Tacrolimus is a lipid of Polyketides (PK) class. Tacrolimus is associated with abnormalities such as Renal glomerular disease. The involved functions are known as inhibitors, Fungicidal activity, Metabolic Inhibition, Excretory function and Dephosphorylation. Tacrolimus often locates in Hepatic, Mitochondrial matrix and Inner mitochondrial membrane. The associated genes with Tacrolimus are RHOA gene and BGN gene.

Cross Reference

Introduction

To understand associated biological information of tacrolimus, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with tacrolimus?

tacrolimus is suspected in Renal glomerular disease, Candidiasis, Mycoses, PARKINSON DISEASE, LATE-ONSET, Morphologically altered structure, Skin Diseases, Infectious and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with tacrolimus

MeSH term MeSH ID Detail
Mycobacterium Infections, Nontuberculous D009165 8 associated lipids
Nail Diseases D009260 2 associated lipids
Paronychia D010304 3 associated lipids
Duodenal Ulcer D004381 12 associated lipids
Dyspnea D004417 10 associated lipids
Vascular Diseases D014652 16 associated lipids
Heart Defects, Congenital D006330 20 associated lipids
Listeriosis D008088 12 associated lipids
Connective Tissue Diseases D003240 2 associated lipids
Ascites D001201 25 associated lipids
Albuminuria D000419 18 associated lipids
Anemia D000740 21 associated lipids
Osteomalacia D010018 5 associated lipids
Tremor D014202 15 associated lipids
Pemphigoid, Bullous D010391 8 associated lipids
Vasculitis D014657 14 associated lipids
Hypothermia D007035 19 associated lipids
Parkinson Disease D010300 53 associated lipids
Down Syndrome D004314 18 associated lipids
Adrenal Insufficiency D000309 3 associated lipids
Keloid D007627 12 associated lipids
Nephritis D009393 19 associated lipids
Food Hypersensitivity D005512 7 associated lipids
Respiration Disorders D012120 5 associated lipids
Thymus Neoplasms D013953 15 associated lipids
Uterine Cervical Dysplasia D002578 2 associated lipids
Facial Neoplasms D005153 3 associated lipids
Dysgammaglobulinemia D004406 3 associated lipids
Influenza, Human D007251 11 associated lipids
Immune System Diseases D007154 3 associated lipids
Headache D006261 4 associated lipids
Cystitis D003556 23 associated lipids
Sarcoma, Kaposi D012514 6 associated lipids
HIV Infections D015658 20 associated lipids
Drug Eruptions D003875 30 associated lipids
Folliculitis D005499 7 associated lipids
Blindness D001766 6 associated lipids
Oliguria D009846 2 associated lipids
Dyskinesia, Drug-Induced D004409 15 associated lipids
Dermatitis, Allergic Contact D017449 20 associated lipids
Graves Disease D006111 6 associated lipids
Peptic Ulcer Perforation D010439 3 associated lipids
Gout D006073 4 associated lipids
Papillomavirus Infections D030361 4 associated lipids
Choline Deficiency D002796 16 associated lipids
Anemia, Hemolytic, Autoimmune D000744 5 associated lipids
Biliary Fistula D001658 13 associated lipids
Glomerulonephritis, Membranoproliferative D015432 3 associated lipids
Glomerulonephritis, Membranous D015433 6 associated lipids
Renal Insufficiency D051437 8 associated lipids
Per page 10 20 50 100 | Total 613

PubChem Associated disorders and diseases

What pathways are associated with tacrolimus

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with tacrolimus?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with tacrolimus?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with tacrolimus?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with tacrolimus?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with tacrolimus?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with tacrolimus

Download all related citations
Per page 10 20 50 100 | Total 15051
Authors Title Published Journal PubMed Link
McAlister VC et al. A clinical pharmacokinetic study of tacrolimus and sirolimus combination immunosuppression comparing simultaneous to separated administration. 2002 Ther Drug Monit pmid:12021624
Bilmen JG et al. The inhibition of the sarcoplasmic/endoplasmic reticulum Ca2+-ATPase by macrocyclic lactones and cyclosporin A. 2002 Biochem. J. pmid:12022919
Nashan B et al. Clinical validation studies of Neoral C(2) monitoring: a review. 2002 Transplantation pmid:12023607
Ibarra FR et al. Intracellular sodium modulates the state of protein kinase C phosphorylation of rat proximal tubule Na+,K+-ATPase. 2002 Acta Physiol. Scand. pmid:12028137
Ishani A et al. Predictors of renal function following lung or heart-lung transplantation. 2002 Kidney Int. pmid:12028464
Streit F et al. Rapid liquid chromatography-tandem mass spectrometry routine method for simultaneous determination of sirolimus, everolimus, tacrolimus, and cyclosporin A in whole blood. 2002 Clin. Chem. pmid:12029019
Van Vlem B et al. In vitro evaluation of motilin agonism by macrolide immunosuppressive drugs. 2002 Nephrol. Dial. Transplant. pmid:12032184
Tzakis AG et al. Campath-1H in intestinal and multivisceral transplantation: preliminary data. 2002 Transplant. Proc. pmid:12034248
Allers C et al. Tacrolimus, daclizumab, sirolimus, and budesonide after small bowel transplantation in order to reduce nephrotoxicity. 2002 Transplant. Proc. pmid:12034251
Ishikawa T et al. Intestinal function and morphology after ex vivo irradiated small bowel transplantation. 2002 Transplant. Proc. pmid:12034274
Sano N et al. Oral FK 506 blood levels are elevated in pig short bowel model: further investigations with co-administration of an intestinal CYP3A4 inhibitor. 2002 Transplant. Proc. pmid:12034301
Rabkin JM et al. Immunosuppression impact on long-term cardiovascular complications after liver transplantation. 2002 Am. J. Surg. pmid:12034401
Dissemond J et al. [Pimecrolimus (SDZ ASM 981). Current state of research]. 2002 Dtsch. Med. Wochenschr. pmid:12035117
Jones TE and Morris RG Pharmacokinetic interaction between tacrolimus and diltiazem: dose-response relationship in kidney and liver transplant recipients. 2002 Clin Pharmacokinet pmid:12036394
Czaja AJ Autoimmune hepatitis after liver transplantation and other lessons of self-intolerance. 2002 Liver Transpl. pmid:12037780
Luan FL et al. Rapamycin blocks tumor progression: unlinking immunosuppression from antitumor efficacy. 2002 Transplantation pmid:12042641
Smets F et al. Ratio between Epstein-Barr viral load and anti-Epstein-Barr virus specific T-cell response as a predictive marker of posttransplant lymphoproliferative disease. 2002 Transplantation pmid:12042647
van Rijen MM et al. CD154 is expressed during treatment with calcineurin inhibitors after organ transplantation. 2002 Transplantation pmid:12042657
Bouret S et al. Galanin modulates the activity of proopiomelanocortin neurons in the isolated mediobasal hypothalamus of the male rat. 2002 Neuroscience pmid:12044465
Saito S et al. Cyclosporin A inhibits angiotensin II-induced c-Jun NH(2)-terminal kinase activation but not protein synthesis in vascular smooth muscle cells. 2002 Eur. J. Pharmacol. pmid:12044791
Myckatyn TM et al. The effects of rapamycin in murine peripheral nerve isografts and allografts. 2002 Plast. Reconstr. Surg. pmid:12045568
Topical pimecrolimus (Elidel) for treatment of atopic dermatitis. 2002 Med Lett Drugs Ther pmid:12045753
Gupta AK et al. Tacrolimus: a review of its use for the management of dermatoses. 2002 J Eur Acad Dermatol Venereol pmid:12046809
Blackmore M et al. The effects of haloalkene cysteine conjugates on cytosolic free calcium levels in LLC-PK(1) cells--studies utilising digital imaging fluorescence microscopy. 2002 Toxicology pmid:12049843
Kimble RM et al. Successful topical tacrolimus (FK506) therapy in a child with pyoderma gangrenosum. 2002 J. Pediatr. Gastroenterol. Nutr. pmid:12050584
Kakegawa T et al. Rapamycin induces binding activity to the terminal oligopyrimidine tract of ribosomal protein mRNA in rats. 2002 Arch. Biochem. Biophys. pmid:12051685
Deters M et al. Sirolimus/cyclosporine/tacrolimus interactions on bile flow and biliary excretion of immunosuppressants in a subchronic bile fistula rat model. 2002 Br. J. Pharmacol. pmid:12055139
Peherstorfer E et al. Effects of microinjection of synthetic Bcl-2 domain peptides on apoptosis of renal tubular epithelial cells. 2002 Am. J. Physiol. Renal Physiol. pmid:12060601
Ishchenko AV and Shakhnovich EI SMall Molecule Growth 2001 (SMoG2001): an improved knowledge-based scoring function for protein-ligand interactions. 2002 J. Med. Chem. pmid:12061879
Yamamoto K et al. Myocardial stiffness is determined by ventricular fibrosis, but not by compensatory or excessive hypertrophy in hypertensive heart. 2002 Cardiovasc. Res. pmid:12062710
Oz HS et al. Effects of immunomodulators on acute Trypanosoma Cruzi infection in mice. 2002 Med. Sci. Monit. pmid:12070425
Erdogan M et al. Liposomal tacrolimus lotion as a novel topical agent for treatment of immune-mediated skin disorders: experimental studies in a murine model. 2002 Br. J. Dermatol. pmid:12072063
Kilinç M et al. FK 506-induced fulminant leukoencephalopathy after kidney transplantation: case report. 2002 Transplant. Proc. pmid:12072309
Fahlke J et al. Staggered immunosuppression with the interleukin-2 receptor antagonist daclizumab combined with tacrolimus, prednisolone, and mycophenolate mofetil after orthotopic liver transplantation: a pilot efficacy and safety study. 2002 Transplant. Proc. pmid:12072328
Teebken OE et al. Primary immunosuppression with tacrolimus and mycophenolate mofetil versus cyclosporine and azathioprine in heart transplant recipients. 2002 Transplant. Proc. pmid:12072335
Miyazawa H et al. Graft immunomodulation by donor irradiation and recipient-specific bone marrow cells in rat small bowel transplantation. 2002 Transplant. Proc. pmid:12072357
McPherson M et al. Drug receptor identification from multiple tissues using cellular-derived mRNA display libraries. 2002 Chem. Biol. pmid:12079780
Sobie EA et al. Termination of cardiac Ca(2+) sparks: an investigative mathematical model of calcium-induced calcium release. 2002 Biophys. J. pmid:12080100
Ferro CJ et al. Central aortic pressure augmentation in stable renal transplant recipients. 2002 Kidney Int. pmid:12081575
Kelly D Transplantation--new beginnings and new horizons. 2002 May-Jun J. Pediatr. Gastroenterol. Nutr. pmid:12082389
Fuchs M et al. Tacrolimus enhances irritation in a 5-day human irritancy in vivo model. 2002 Contact Derm. pmid:12084083
Jiang H et al. Tacrolimus and cyclosporine differ in their capacity to overcome ongoing allograft rejection as a result of their differential abilities to inhibit interleukin-10 production. 2002 Transplantation pmid:12085006
Grudé P et al. MDR1 gene expression in peripheral blood mononuclear cells after liver transplantation. 2002 Transplantation pmid:12085008
Xu X et al. FKBP12 is the only FK506 binding protein mediating T-cell inhibition by the immunosuppressant FK506. 2002 Transplantation pmid:12085010
Nomura T et al. Enhancement by cyclosporin A of taxol-induced apoptosis of human urinary bladder cancer cells. 2002 Urol. Res. pmid:12086014
van Duijnhoven EM et al. A late episode of post-transplant diabetes mellitus during active hepatitis C infection in a renal allograft recipient using tacrolimus. 2002 Am. J. Kidney Dis. pmid:12087579
Soldevila G et al. Analysis of the individual role of the TCRzeta chain in transgenic mice after conditional activation with chemical inducers of dimerization. 2001 Cell. Immunol. pmid:12088411
Williams H New treatments for atopic dermatitis. 2002 BMJ pmid:12089073
Bornhövd EC et al. Immunomodulatory macrolactams for topical treatment of inflammatory skin diseases. 2002 Curr Opin Investig Drugs pmid:12090543
Schopf RE Pimecrolimus. Novartis. 2002 Curr Opin Investig Drugs pmid:12090545
Cos J et al. FK506 in the maturation of dendritic cells. 2002 Haematologica pmid:12091117
Agarwala S et al. Evaluation of renal function in transplant patients on tacrolimus therapy. 2002 J Clin Pharmacol pmid:12092747
Wahn U et al. Efficacy and safety of pimecrolimus cream in the long-term management of atopic dermatitis in children. 2002 Pediatrics pmid:12093983
Meier-Kriesche HU and Kaplan B Cyclosporine microemulsion and tacrolimus are associated with decreased chronic allograft failure and improved long-term graft survival as compared with sandimmune. 2002 Am. J. Transplant. pmid:12095048
Walker SL et al. Use of 0.1% tacrolimus ointment in patients with various forms of lupus erythematosus. 2002 Jul-Aug Eur J Dermatol pmid:12095891
Bernard LA et al. Pimecrolimus 1% cream (Elidel) for atopic dermatitis. 2002 Skin Therapy Lett. pmid:12097994
Bultynck G et al. Washing out of lipophilic compounds induces a transient increase in the passive Ca(2+) leak in permeabilized A7r5 cells. 2002 Cell Calcium pmid:12098225
Koefoed-Nielsen PB et al. Blood tacrolimus levels and calcineurin phosphatase activity early after renal transplantation. 2002 Am. J. Transplant. pmid:12099520
Felipe CR et al. The impact of ethnic miscegenation on tacrolimus clinical pharmacokinetics and therapeutic drug monitoring. 2002 Clin Transplant pmid:12099982
Kimball P et al. Comparison of two drug regimens upon clinical outcome among renal transplant recipients with positive flow cytometric crossmatches. 2002 Clin Transplant pmid:12099986
Katoh N et al. Cutaneous sarcoidosis successfully treated with topical tacrolimus. 2002 Br. J. Dermatol. pmid:12100200
Wilhelmi E et al. Organotypic brain-slice cultures from adult rats: approaches for a prolonged culture time. 2002 May-Jun Altern Lab Anim pmid:12106005
Edinger RS et al. Effect of immunosuppressive agents on glucocorticoid receptor function in A6 cells. 2002 Am. J. Physiol. Renal Physiol. pmid:12110508
Jin MB et al. A novel leflunomide derivative, FK778, for immunosuppression after kidney transplantation in dogs. 2002 Surgery pmid:12110798
Okajima S et al. Histological and electrophysiological analysis of the peripheral nerve allografts using an immunosuppressive agent. 2002 Microsc. Res. Tech. pmid:12112423
Reitamo S et al. Topical noncorticosteroid immunomodulation in the treatment of atopic dermatitis. 2002 Am J Clin Dermatol pmid:12113647
Wellington K and Jarvis B Spotlight on topical pimecrolimus in atopic dermatitis. 2002 Am J Clin Dermatol pmid:12113651
Kim MJ et al. Calpain-dependent cleavage of cain/cabin1 activates calcineurin to mediate calcium-triggered cell death. 2002 Proc. Natl. Acad. Sci. U.S.A. pmid:12114545
Cho ML et al. Cyclosporine inhibition of vascular endothelial growth factor production in rheumatoid synovial fibroblasts. 2002 Arthritis Rheum. pmid:12115224
Kahn K and Bruice TC Parameterization of OPLS-AA force field for the conformational analysis of macrocyclic polyketides. 2002 J Comput Chem pmid:12116403
Nazzaro G and Cestari R Topical tacrolimus ointment in ulcerative lichen planus: an alternative therapeutic approach. 2002 Jul-Aug Eur J Dermatol pmid:12118424
Montgomery SP et al. Efficacy and toxicity of a protocol using sirolimus, tacrolimus and daclizumab in a nonhuman primate renal allotransplant model. 2002 Am. J. Transplant. pmid:12118862
Ahsan N et al. Limited dose monoclonal IL-2R antibody induction protocol after primary kidney transplantation. 2002 Am. J. Transplant. pmid:12118902
[Corticosteroid-free therapy for the neurodermatitis patient. Rapid cessation for tormenting urticaria]. 2002 MMW Fortschr Med pmid:12119889
Rico MJ and Lawrence I Tacrolimus ointment for the treatment of atopic dermatitis: clinical and pharmacologic effects. 2002 May-Jun Allergy Asthma Proc pmid:12125507
Su M et al. Acute tacrolimus overdose without significant toxicity. 2002 J. Toxicol. Clin. Toxicol. pmid:12126198
Egi H et al. Downregulation of both interleukin-12 and interleukin-2 in heart allografts by pretransplant host treatment with granulocyte colony-stimulating factor and tacrolimus. 2002 Cytokine pmid:12126653
Hackstein H et al. Rapamycin inhibits macropinocytosis and mannose receptor-mediated endocytosis by bone marrow-derived dendritic cells. 2002 Blood pmid:12130531
Bernard LA and Eichenfield LF Topical immunomodulators for atopic dermatitis. 2002 Curr. Opin. Pediatr. pmid:12130904
Gloor JM et al. Subclinical rejection in tacrolimus-treated renal transplant recipients. 2002 Transplantation pmid:12131699
Verleden GM et al. Successful conversion from cyclosporine to tacrolimus for gastric motor dysfunction in a lung transplant recipient. 2002 Transplantation pmid:12131703
Siemionow M and Ozer K Advances in composite tissue allograft transplantation as related to the hand and upper extremity. 2002 J Hand Surg Am pmid:12132078
Margreiter R et al. A double-hand transplant can be worth the effort! 2002 Transplantation pmid:12134104
Tian L et al. Association of the CD134/CD134L costimulatory pathway with acute rejection of small bowel allograft. 2002 Transplantation pmid:12134113
Perrino BA et al. Substrate selectivity and sensitivity to inhibition by FK506 and cyclosporin A of calcineurin heterodimers composed of the alpha or beta catalytic subunit. 2002 Eur. J. Biochem. pmid:12135494
Walzel H et al. Galectin-induced activation of the transcription factors NFAT and AP-1 in human Jurkat T-lymphocytes. 2002 Cell. Signal. pmid:12135707
Pustisek N et al. Tacrolimus ointment: a new therapy for atopic dermatitis--review of the literature. 2002 Acta Dermatovenerol Croat pmid:12137728
Higashigawa M and Komada Y Role of Ca2+ in the intracellular signaling pathway of anti-IgM-induced apoptosis in the human B-cell line, MBC-1, established from Burkitt lymphoma. 2002 Int. J. Hematol. pmid:12138894
Yango A et al. Successful treatment of tacrolimus-associated thrombotic microangiopathy with sirolimus conversion and plasma exchange. 2002 Clin. Nephrol. pmid:12141412
Adachi S and Iwata M Duration of calcineurin and Erk signals regulates CD4/CD8 lineage commitment of thymocytes. 2002 Cell. Immunol. pmid:12142035
Kuzuya T et al. Interference of hematocrit in the tacrolimus II microparticle enzyme immunoassay. 2002 Ther Drug Monit pmid:12142635
Stolk LM et al. Trough levels of tacrolimus. 2002 Ther Drug Monit pmid:12142646
Ducobu J [Metabolic modifications related to immunosuppressive drugs]. 2002 Rev Med Brux pmid:12143154
Hämäläinen M et al. Calcineurin inhibitors, cyclosporin A and tacrolimus inhibit expression of inducible nitric oxide synthase in colon epithelial and macrophage cell lines. 2002 Eur. J. Pharmacol. pmid:12144947
Jørgensen K et al. C2 (2-h) levels are not superior to trough levels as estimates of the area under the curve in tacrolimus-treated renal-transplant patients. 2002 Nephrol. Dial. Transplant. pmid:12147799
Therapondos G et al. Cardiac function after orthotopic liver transplantation and the effects of immunosuppression: a prospective randomized trial comparing cyclosporin (Neoral) and tacrolimus. 2002 Liver Transpl. pmid:12149762
Lee KH et al. Delayed tacrolimus is safe with basiliximab induction therapy. 2002 Liver Transpl. pmid:12149770
Hricik DE et al. Outcomes of African American kidney transplant recipients treated with sirolimus, tacrolimus, and corticosteroids. 2002 Transplantation pmid:12151730
Ogawa H et al. Combination of tacrolimus, methotrexate, and methylprednisolone prevents acute but not chronic graft-versus-host disease in unrelated bone marrow transplantation. 2002 Transplantation pmid:12151737
Nagata K et al. AT1 receptor blockade reduces cardiac calcineurin activity in hypertensive rats. 2002 Hypertension pmid:12154108